DIA465.06-0.42 -0.09%
SPY655.83+0.59 0.09%
QQQ584.98+0.67 0.11%

Rici Healthcare Holdings First Half 2025 Earnings: EPS: CN¥0.035 (vs CN¥0.053 in 1H 2024)

Simply Wall St·09/23/2025 22:49:41
Listen to the news

Rici Healthcare Holdings (HKG:1526) First Half 2025 Results

Key Financial Results

  • Revenue: CN¥1.14b (down 7.0% from 1H 2024).
  • Net income: CN¥55.9m (down 34% from 1H 2024).
  • Profit margin: 4.9% (down from 6.9% in 1H 2024). The decrease in margin was driven by lower revenue.
  • EPS: CN¥0.035 (down from CN¥0.053 in 1H 2024).
earnings-and-revenue-history
SEHK:1526 Earnings and Revenue History September 23rd 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Rici Healthcare Holdings' share price is broadly unchanged from a week ago.

Balance Sheet Analysis

While it's very important to consider the profit and loss statement, you can also learn a lot about a company by looking at its balance sheet. We have a graphic representation of Rici Healthcare Holdings' balance sheet and an in-depth analysis of the company's financial position.

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.